RONALD HUNT - 25 Mar 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Ronald Hunt
Issuer symbol
ITRM
Transactions as of
25 Mar 2022
Transactions value $
$0
Form type
4
Filing time
29 Mar 2022, 20:00:20 UTC
Previous filing
05 Jan 2022
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Award $0 +17,955 $0 17,955 25 Mar 2022 Ordinary Shares 17,955 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.
F2 Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on January 1, 2023.